TAC 003
Alternative Names: Nectin-4 TRAACLatest Information Update: 02 Dec 2022
At a glance
- Originator Tallac Therapeutics
- Class Antibodies; Antineoplastics; Drug conjugates; Immunoconjugates; Immunotherapies; Oligonucleotides
- Mechanism of Action Toll-like receptor 9 agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Preclinical Solid tumours